A follow-up survey of 42 048 subjects tested with epstein-barr viral serology in a high-incidence area of nasopharyngeal carcinoma

Chinese-German Journal of Clinical Oncology

Volumn 1, Issue 4, 2002, Pages 222-225

  Ji, Mingfang ^a   Ou, Xingtai ^a   Zong, Yongsheng ^b   Zheng, Shouang ^a   Guo, Yuanqmg ^a   Liang, Jmsheng ^a   Cheng, Weimin ^a   Wang, Dekun ^a  

^a Cancer Research Institute of Zhongshan City   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

EBV; Follow up; NPC; Screening; Serology

Indexed keywords

EID: 33644899832     PISSN: 16101979     EISSN: 16139089     Source Type: Journal    
DOI: 10.1007/BF02838437     Document Type: Review

References (14)

1. Henle G, Henle W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer
2. Zeng Y, Zhang LG, Li HY, et al. Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China. Int J Cancer, 1982, 29:139-141.
3. Zheng SA, Liang JS, Guo YQ, et al. Dynamic observation on the incidence and mortality rate of the nasopharyngeal carcinoma ( NPC ) in Zhongshan City 1970-1984. Chin J Epidemiol, 1991, 12:106-110.
4. Zong YS, Li JY, Peng XY, et al. Nasopharyngeal carcinoma ( NPC ) mortality rates in two districts of Guangdong Province and their relation to IgA antibody level against EB virus capsid antigen. Chin J Oncol, 1992, 14:103-105.
5. Zong YS, Sham JS, Ng MH, et al. hnmunoglobulin A against viral capsid antigen of Epstein-Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma. Cancer, 1992, 69:3-7.
6. Liu YX, Zeng Y, Dong WP, et al. Detection of EB virus-specific IgA antibody from patients with nasopharyngeal carcinoma by immunoenzymic method. Chin J Oncol, 1979, 1:8-12.
7. Shanmugaratnam K, Sobin LH. The World Health Organization histological classification of tumors of the upper respiratory tract and ear. A commentary on the second edition. Cancer, 1993, 71 : 2689-2697.
8. Sobin LH, Fleming ID. TNM Classification of Malignant Tumors, fifth edition ( 1997 ). Union International Contre le Cancer and the American Joint Committee on Cancer. Cancer, 1997, 80:1803-1804.
9. Zhang EP, Lian PG, Cai KL, et al. Radiotherapy of nasopharyngeal carcinoma: prognostic factors based on a lO-year follow-up of 1302 patients. Int J Radiat Oncol Biol Phys, 1989, 16 : 301-305.
10. Hong MH, Mai HQ, Min HQ, et al. A comparison of the Chinese 1992 and fifth-edition International Union Against Cancer staging systems for staging uasopharyngeal carcinoma. Cancer, 2000, 89: 242-247.
11. Sham JS, Wei WI, Zong YS, et al. Detection of subclinical nasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy. Lancet, 1990, 335 : 371-374.
12. , iu MY, Chang YL, Ma J, et al. Evaluation of multiple antibodies to Epstein-Barr virus as markers for detecting patients with nasopharyngeal carcinoma. J Med Virol, 1997, 52:262-269.
13. Zeng Y, Zhang LG, Wu YC, et al. Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China. Int J Cancer, 1985, 36:545-547.
14. Hsu JL, Glaser SL. Epstein-Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit Rev Oncol Hematol, 2000, 34 : 27-53.